RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bionano Genomics Stock

Bionano Genomics ROA 2025

Bionano Genomics ROA

-1.46

Ticker

BNGO

ISIN

US09075F4046

WKN

A2JRLZ

In 2025, Bionano Genomics's return on assets (ROA) was -1.46, a 34.74% increase from the -1.08 ROA in the previous year.

Bionano Genomics Aktienanalyse

What does Bionano Genomics do?

Bionano Genomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Bionano Genomics's Return on Assets (ROA)

Bionano Genomics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Bionano Genomics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Bionano Genomics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Bionano Genomics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Bionano Genomics stock

What is the Return on Assets (ROA) of Bionano Genomics this year?

The Return on Assets (ROA) of Bionano Genomics is -1.46 undefined this year.

What was the ROA of Bionano Genomics compared to the previous year?

The ROA of Bionano Genomics has increased by 34.74% compared to the previous year.

What consequences do high ROA have for investors of Bionano Genomics?

A high ROA is advantageous for investors of Bionano Genomics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Bionano Genomics?

A low ROA can be unfavorable for investors of Bionano Genomics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Bionano Genomics affect the company?

An increase in ROA of Bionano Genomics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Bionano Genomics impact the company?

A reduction in the ROA of Bionano Genomics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Bionano Genomics?

Some factors that can influence the ROA of Bionano Genomics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Bionano Genomics important for investors?

The ROA of Bionano Genomics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Bionano Genomics take to improve ROA?

To improve ROA, Bionano Genomics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Bionano Genomics pay?

Over the past 12 months, Bionano Genomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionano Genomics is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionano Genomics?

The current dividend yield of Bionano Genomics is .

When does Bionano Genomics pay dividends?

Bionano Genomics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionano Genomics?

Bionano Genomics paid dividends every year for the past 0 years.

What is the dividend of Bionano Genomics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionano Genomics located?

Bionano Genomics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionano Genomics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionano Genomics from 10/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Bionano Genomics pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Bionano Genomics in the year 2024?

In the year 2024, Bionano Genomics distributed 0 USD as dividends.

In which currency does Bionano Genomics pay out the dividend?

The dividends of Bionano Genomics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bionano Genomics

Our stock analysis for Bionano Genomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionano Genomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.